Decreasing striatal 6-FDOPA uptake with increasing duration of cocaine withdrawal

Neuropsychopharmacology

Volumn 17, Issue 6, 1997, Pages 402-409

  Wu, Joseph C ^a   Bell, Kate ^c   Najafi, Ahmad ^a   Widmark, Cliff ^c   Keator, Dave ^a   Tang, Cheuk ^d   Klein, Eric ^a   Bunney, Blynn G ^a   Fallon, James ^b   Bunney, William E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Brain radionuclide imaging; Cocaine; Dopa analogs and derivatives; Dopamine metabolism; Emission computed tomography; Stimulants

Indexed keywords

6 FLUORODOPA F 18; COCAINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINERGIC ACTIVITY; DRUG UPTAKE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; NORMAL HUMAN; PRIORITY JOURNAL; SCINTISCANNING; WITHDRAWAL SYNDROME;

ADULT; BRAIN CHEMISTRY; COCAINE; DIHYDROXYPHENYLALANINE; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; MALE; NARCOTICS; NEOSTRIATUM; SUBSTANCE WITHDRAWAL SYNDROME; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 17144436678     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(97)00089-4     Document Type: Article

References (44)

1. Ackerman JM, White FJ (1992): Decreased activity of rat A10 dopamine neurons following withdrawal from repeated cocaine. Eur J Pharmacol 218:171-173
2. Calne DB, Langsten JW, Martin WR, Stoessl AJ, Ruth TJ, Adam MJ, Pate BD, Schulzer M (1985): Positron emission tomography after MPTP: Observations relating to the cause of Parkinson's disease. Nature 317:246-248
3. Carroll KM, Rounsaville BJ, Nich C, Gordon LT, Wirtz PW, Gawin F (1994): One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence. Delayed emergence of psychotherapy effects. Arch Gen Psychiatry 51:989-997
4. Childress A, Ehrman R, McLellan AT, O'Brien C (1988a): Conditioned craving and arousal in cocaine addiction: A preliminary report. NIDA Res Monogr 81:74-80
5. Childress AR, McLellan AT, Ehrman R, O'Brien CP (1988b): Classically conditioned responses in opiod and cocaine dependence: A role in relapse? NIDA Res Monogr 84:25-43
6. Dackis CA, Gold MS (1985): New concepts in cocaine addiction: The dopamine depletion hypothesis. Neurosci Biobehav Rev 9:469-477
7. Fung YK, Richard LA (1994): Behavioral consequences of cocaine withdrawal in rats. J Pharm Pharmacol 46:150-152
8. Garnett ES, Firnau G, Nahmias C (1983): Dopamine visualized in the basal ganglia of living man. Nature 305:137-138
9. Gawin FH, Kleber HD (1986): Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations. Arch Gen Psychiatry 43:103-113
10. Giros B, Jaber M, Jones SR, Wightman RM, Caron M (1996): Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606-612
11. Good P (1994): Permutation Test: A Practical Guide to Resampling Methods for Testing Hypothesis, 1 ed. Berlin, Springer-Verlag
12. Grace AA (1995): The tonic/phase model of dopamine system regulation: Its relevance for understanding how stimulant abuse can alter basal ganglia function. Drug Alcohol Depend 37:111-129
13. Grant S, Newlin D, Villemagne VL, Phillips RL, Liu X, Kimes AS, Matsunage T, Contoreggi C, London ED (1995): Cocaine craving: a PET FDG study. J Nucl Med 36:43p
14. Hadjiconstantinou M, Wemlinger TA, Sylvia CP, Hubble JP, Neff NH (1993): Aromatic L-amino acid decarboxylase activity of mouse striatum is modulated via dopamine receptors. J Neurochem 60:2175-2180
15. Kish SJ, Zhong XH, Hornykiewicz O, Haycock JW (1995): Striatal 3,4-dihydroxyphenylalanine decarboxylase in aging: Disparity between postmortem and positron emission tomography studies? Ann Neurol 38:260-264
16. Li XM, Juorio AV, Bouton AA (1994): Induction of aromatic L-amino acid decarboxylase mRNA by interleukin-1 beta and prostaglandin E2 in PC12 cells. Neurochem Res 19:591-595
17. London ED, Cascella NG, Wong DF, Phillips RL, Dannals RF, Links JM, Herning R, Grayson R, Jaffe JH, Wagner HN Jr (1990): Cocaine-induced reduction of glucose utilization in human brain. A study using positron emission tomography and [fluorine 18]-fluorodeoxyglucose. Arch Gen Psychiatry 47:567-574
18. Markou A, Koob GF (1991): Postcocaine anhedonia. An animal model of cocaine withdrawal. Neuropsychopharmacology 4:17-26
19. Martin SD, Yeragani VK, Lodhi R, Galloway MP (1989a): Clinical ratings and plasma HVA during cocaine abstinence. Biol Psychiatry 26:356-362
20. Martin WR, Palmer MR, Patlak CS, Calne DB (1989b): Nigrostriatal function in humans studied with positron emission tomography. Ann Neurol 26:535-542
21. Nagatsu T, Levitt M, Udenfriend S (1964): Tyrosine hydroxylase: the initial steps in norepinephrine biosynthesis. J Biol Chem 239:2910-2920
22. Najafi A (1995): Measures and pitfalls for successful preparation of "no carrier added" asymmetric 6-[18F]fluor-L-dopa from 18F-fluoride ion. Nucl Med Biol 22:395-397
23. Neff NH, Hadjiconstantinou M (1995): Aromatic L-amino acid decarboxylase modulation and Parkinson's disease. Prog Brain Res 106:91-97
24. Paredes A, Khasla HK, Anglin PP, Potter C (1991): Natural history of cocaine abuse: From first cocaine use to two years after treatment. NIDA Res Monogr 119:480
25. Parsons LH, Smith AD, Justice JB Jr (1991): Basal extracellular dopamine is decreased in the rat nucleus accumbens during abstinence from chronic cocaine. Synapse 9:60-65
26. Patlak CS, Blasberg RG (1985): Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab 5:584-590
27. Patlak CS, Blasberg RG, Fenstermacher JD (1983): Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 3:1-7
28. Pollack S, Bruce P, Borenstein M, Lieberman J (1994): The resampling method of statistical analysis. Psychopharmacol Bull 30:227-234
29. Robbins SJ, Ehrman RN, Childress AR, O'Brien CP (1992): Using cue reactivity to screen medications for cocaine abuse: a test of amantadine hydrochloride [see comments]. Addict Behav 17:491-499
30. Robertson MW, Leslie CA, Bennett JP Jr (1991): Apparent synaptic dopamine deficiency induced by withdrawal from chronic cocaine treatment. Brain Res 538:337-339
31. Rossetti ZL, Hmaidan Y, Gessa GL (1992): Marked inhibition of mesolimbic dopamine release: A common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur J Pharmacol 221:227-234
32. Sarnyai Z, Biro E, Gardi J, Vecsernyes M, Julesz J, Telegdy G (1995): Brain corticotropin-releasing factor mediates "anxiety-like" behavior induced by cocaine withdrawal in rats. Brain Res 675:89-97
33. Satel SL, Price LH, Palumbo JM, McDougle CJ, Krystal JH, Gawin F, Charney DS, Heninger GR, Kleber HD (1991): Clinical phenomenology and neurobiology of cocaine abstinence: A prospective inpatient study [see comments]. Am J Psychiatry 148:1712-1716
34. Sobol IM (1975): The Monte Carlo Method, 1st ed. Moscow, Mir Publishers
35. Volkow ND, Mullani N, Gould KL, Adler S, Krajewski K (1988): Cerebral blood flow in chronic cocaine users: A study with positron emission tomography. Br J Psychiatry 152:641-648
36. Volkow ND, Fowler JS, Wolf AP, Hitzemann R, Dewey S, Bendriem B, Alpert R, Hoff A (1991): Changes in brain glucose metabolism in cocaine dependence and withdrawal [see comments]. Am J Psychiatry 148:621-626
37. Volkow ND, Fowler JS, Logan J, Wang GJ, Hitzemann R, MacGregor R, Dewey SL (1992a): Decreased binding of 11-C-cocaine in the brain of cocaine addicts. J Nucl Med 33:888-898
38. Volkow ND, Hitzemann R, Wang GJ, Fowler JS, Wolf AP, Dewey SL, Handlesman L (1992b): Long-term frontal brain metabolic changes in cocaine abusers [published erratum appears in Synapse 1992; 12(1):86]. Synapse 11:184-190
39. 2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14:169-177
40. Weddington WW, Brown BS, Haertzen CA, Cone EJ, Dax EM, Herning RI, Michaelson BS (1990): Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts. A controlled, residential study. Arch Gen Psychiatry 47:861-868
41. Weiss F, Markou A, Lorang MT, Koob GF (1992): Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Res 593:314-318
42. Widman JC (1988): Monte Carlo simulation in nuclear medicine. In Morin RL (ed), Monte Carlo Simulation in the Radiological Sciences, 1st ed. Boca Raton, FL, CRC Press, pp 193-208
43. Withers NW, Pulivirenti L, Koob GF, Gillin JC (1995): Cocaine abuse and dependence. J Clin Psychopharmacol 15:63-78
44. Zhu MY, Juorio AV, Paterson IA, Boulton AA (1994): Regulation of aromatic L-amino acid decarboxylase in rat striatal synaptosomes: Effects of dopamine receptor agonists and antagonists. Br J Pharmacol 112:23-30